# Barriers to good-quality cancer medicines in Cameroon, as regulators and frontline staff see them

Source: https://onco.cc/key-papers/paper-saidu-cancer-medicines-barriers-cameroon-pgph-2026/  
OnCo record `paper-saidu-cancer-medicines-barriers-cameroon-pgph-2026` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Interviews with 57 people across Cameroon's chemotherapy supply chain found weak regulation, underfunded regulatory work and high prices encouraging substandard cancer medicines and treatment.

## Summary

Published as "Barriers to accessing high-quality cancer medicines in Cameroon. A qualitative study of the views and practices of regulators and frontline healthcare providers". A cross-sectional qualitative study combining a document review with interviews of 57 stakeholders working in regulation, procurement, quality control and use of chemotherapy: 25 pharmacists, 14 medical oncologists, 12 oncology nurses, five drug distributors and one regulator, interviewed in Yaoundé and Douala in October 2023.

## Fields

- Kind: Key paper
- Last checked: 2026-11-11
- Journal: PLOS Global Public Health
- Year: 2026
- DOI: 10.1371/journal.pgph.0005370
- Authors: Saidu Y, Makia MC, Frambo A, et al.
- Findings: Weak regulatory systems, inadequate funding for regulatory activities and a lack of core competencies among regulatory staff affected the quality of chemotherapy medicines.; The high cost of cancer medicines affected access to quality products and the care given to patients who could not afford high-priced products.; With no point-of-care testing tools, these weaknesses appeared to encourage substandard medicines and the use of substandard therapies or protocols.
- What it means: Cancer medicines in Cameroon are often paid for by families, and the people who regulate and use them describe a market where cheaper products of uncertain quality fill the gap.
- Caveats: Qualitative; it does not measure how many products are substandard.

## Sources

- PLOS Glob Public Health 2026: https://doi.org/10.1371/journal.pgph.0005370
- PubMed: https://pubmed.ncbi.nlm.nih.gov/41576006/

## Connected records

- institutions: [Department of Pharmacy, Medicines and Laboratories, Cameroon (DPML)](https://onco.cc/institutions/dpml-cameroon/), [Ministry of Public Health, Cameroon (MINSANTE)](https://onco.cc/institutions/cameroon-ministry-of-public-health/)

---
JSON: https://onco.cc/api/v1/entities/paper-saidu-cancer-medicines-barriers-cameroon-pgph-2026.json